Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Asset Writedowns and Impairment (2019 - 2021)

Historic Asset Writedowns and Impairment for AVITA Medical (AVHHL) over the last 3 years, with Q4 2021 value amounting to $23000.0.

  • AVITA Medical's Asset Writedowns and Impairment rose 56000.0% to $23000.0 in Q4 2021 from the same period last year, while for Dec 2023 it was $42000.0, marking a year-over-year change of. This contributed to the annual value of $810000.0 for FY2025, which is 6632.44% up from last year.
  • Latest data reveals that AVITA Medical reported Asset Writedowns and Impairment of $23000.0 as of Q4 2021, which was up 56000.0% from $19000.0 recorded in Q3 2021.
  • In the past 5 years, AVITA Medical's Asset Writedowns and Impairment registered a high of $23000.0 during Q4 2021, and its lowest value of -$77000.0 during Q3 2020.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $9500.0 (2019), whereas its average is -$3500.0.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 106250.0% in 2020, then surged by 56000.0% in 2021.
  • Quarter analysis of 3 years shows AVITA Medical's Asset Writedowns and Impairment stood at $11000.0 in 2019, then plummeted by 145.45% to -$5000.0 in 2020, then surged by 560.0% to $23000.0 in 2021.
  • Its Asset Writedowns and Impairment stands at $23000.0 for Q4 2021, versus $19000.0 for Q3 2021 and -$5000.0 for Q4 2020.